Advanced search
Publication Cover
Journal of Chemotherapy Volume 34, 2022 - Issue 3
Submit an article Journal homepage
465
Views
5
CrossRef citations to date
0
Altmetric
Anticancer Original Research Papers

Brentuximab vedotin and bendamustine: an effective salvage therapy for relapsed or refractory Hodgkin lymphoma patients

Bahar Uncu Ulua Department of Hematology and Bone Marrow Transplantation Center, University of Health Sciences, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, TurkeyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6230-9519
ORCID Icon,
Mehmet Sinan Dala Department of Hematology and Bone Marrow Transplantation Center, University of Health Sciences, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, TurkeyORCID Iconhttps://orcid.org/0000-0002-5994-2735
ORCID Icon,
İpek Yönal Hindilerdenb Faculty of Medicine, Internal Medicine Department, Division of Hematology, Istanbul University, Istanbul, TurkeyORCID Iconhttps://orcid.org/0000-0003-1353-2367
ORCID Icon,
Olga Meltem Akayc School of Medicine, Department of Hematology, Koç University, İstanbul, TurkeyORCID Iconhttps://orcid.org/0000-0002-6759-1939
ORCID Icon,
Özgür Mehtapd Faculty of Medicine, Department of Hematology, Kocaeli University, Kocaeli, TurkeyORCID Iconhttps://orcid.org/0000-0002-5603-1178
ORCID Icon,
Nurhilal Büyükkurte Department of Hematology, Baskent University School of Medicine, Adana Research and Training Hospital, Adana, TurkeyORCID Iconhttps://orcid.org/0000-0002-0895-4787
ORCID Icon,
Fehmi Hindilerdenf University of Health Sciences, Bakirköy Dr. Sadi Konuk Training and Research Hospital Hematology Clinic, Istanbul, TurkeyORCID Iconhttps://orcid.org/0000-0002-6297-9555
ORCID Icon,
Ahmet Kürşad Güneşg Department of Hematology and Bone Marrow Transplantation, Ankara City Hospital, Ankara, TurkeyORCID Iconhttps://orcid.org/0000-0001-5522-8342
ORCID Icon,
Tuğçe Nur Yiğenoğlua Department of Hematology and Bone Marrow Transplantation Center, University of Health Sciences, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, TurkeyORCID Iconhttps://orcid.org/0000-0001-9962-8882
ORCID Icon,
Semih Başcıa Department of Hematology and Bone Marrow Transplantation Center, University of Health Sciences, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, TurkeyORCID Iconhttps://orcid.org/0000-0003-4304-9245
ORCID Icon,
Merih Kızıl Çakara Department of Hematology and Bone Marrow Transplantation Center, University of Health Sciences, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, TurkeyORCID Iconhttps://orcid.org/0000-0003-0978-0923
ORCID Icon,
Didar Yanardağ Açıkh Department of Internal Medicine and Hematology, Adana City Education and Research Hospital, Adana, TurkeyORCID Iconhttps://orcid.org/0000-0001-7282-0188
ORCID Icon,
Serdal Korkmazi Department of Hematology, University of Health Sciences, Kayseri Training and Research Hospital, Kayseri, TurkeyORCID Iconhttps://orcid.org/0000-0002-5759-2735
ORCID Icon,
Turgay Ulaşj School of Medicine, Department of Internal Medicine, Division of Hematology, Near East University, Nicosia, CyprusORCID Iconhttps://orcid.org/0000-0001-9332-663X
ORCID Icon,
Gülsüm Özetg Department of Hematology and Bone Marrow Transplantation, Ankara City Hospital, Ankara, TurkeyORCID Iconhttps://orcid.org/0000-0003-2658-5978
ORCID Icon,
Burhan Ferhanoğluk Department of Hematology and Oncology, VKV American Hospital, Istanbul, TurkeyORCID Iconhttps://orcid.org/0000-0002-4257-549X
ORCID Icon,
Meliha Nalçacıb Faculty of Medicine, Internal Medicine Department, Division of Hematology, Istanbul University, Istanbul, TurkeyORCID Iconhttps://orcid.org/0000-0002-2555-5024
ORCID Icon &
Fevzi Altuntaşa Department of Hematology and Bone Marrow Transplantation Center, University of Health Sciences, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, TurkeyORCID Iconhttps://orcid.org/0000-0001-6872-3780
ORCID Icon show all
Pages 190-198 | Received 07 Mar 2021, Accepted 01 Sep 2021, Published online: 13 Sep 2021

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Panayotis Kaloyannidis, Mohammed Al Zayer, Mohammed Al Darweesh, Majed Al Batran, Ayed Al Garni, Abdulrahman Al Naim, Hani Al Hashmi & Solaf Kanfar. (2023) Brentuximab vedotin plus bendamustine versus platinum-based regimens as 1st salvage therapy and ‘bridge’ to autologous hematopoietic stem cell transplantation for relapsed/refractory Hodgkin lymphoma. Leukemia & Lymphoma 64:3, pages 742-745.
Read now

Articles from other publishers (4)

H. Miles Prince, Martin Hutchings, Eva Domingo-Domenech, Dennis A. Eichenauer & Ranjana Advani. (2022) Anti-CD30 antibody–drug conjugate therapy in lymphoma: current knowledge, remaining controversies, and future perspectives. Annals of Hematology 102:1, pages 13-29.
Crossref
. (2022) Bendamustine/brentuximab-vedotin. Reactions Weekly 1909:1, pages 129-129.
Crossref
Dinesh Bhurani, Reena Nair, Senthil Rajappa, Suparna Ajit Rao, Nithya Sridharan, Rakesh Reddy Boya, Ganapathi S. Raman, Hari Menon, Arun Seshachalam & Ramesh Nimmagadda. (2022) Real-World Outcomes of Hodgkin Lymphoma: A Multi-Centric Registry From India. Frontiers in Oncology 11.
Crossref
Roser Velasco, Eva Domingo-Domenech & Anna Sureda. (2021) Brentuximab-Induced Peripheral Neurotoxicity: A Multidisciplinary Approach to Manage an Emerging Challenge in Hodgkin Lymphoma Therapy. Cancers 13:23, pages 6125.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.